News from The Netherlands

Researcher Jeroen den Dunnen wanted to do a daratumumab trial and I believe a sonlicromanol trial, but he wasn't able to due to the current constraints of only trying drugs that weren't patented. In Long-Covid ZonMw allowed it though.

Yes, exactly. It's probably a little bit of both though. If we had more leads there might also have been more interest in off-patent drugs.
 
Dutch Health Council urges government action on long Covid

The Dutch Health Council has urged the ministry of health, welfare and sport to increase clarity around long Covid. Although estimates vary of how many people suffer from it, the council puts it at 400,000 people nationwide, many of whom have severe symptoms.

Whether treatment for people suffering from long Covid should be included in the regular healthcare system remains a question of national debate.
...
The new recommendations into understanding chronic post-acute infection syndromes (PAIS), of which long Covid is one, marks a U-turn from the past two years of government policy.

Broadcaster NOS reported that health minister Sophie Hermans believes the regular healthcare system should be responsible for long Covid patients. But the Dutch Health Council says “the estimated large numbers of people with long COVID and other PAIS cannot simply be absorbed into regular care.”

The ministry says it is studying the council’s advice.
 
Journalist Sander Zurhake from the NOS wrote a critical piece about the report.

"Appreciation and Skepticism After the Health Council’s Advice to Take Long Covid Seriously"

 
Back
Top Bottom